2016
DOI: 10.1111/vaa.12342
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of laryngospasm with rocuronium in cats: a dose-finding study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
7
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 15 publications
2
7
0
Order By: Relevance
“…4 It has been suggested that the laryngeal muscles are more resistant to the effects of rocuronium than fibular or radial nerves, which could explain the apparent similarity in onset time between the reported case and earlier work. 4,6 In contrast, a feline study using subjective evaluation of intubating conditions as an outcome found a slower time to peak effect (60 s) with 0.6 mg/kg rocuronium IV. 3 Furthermore, arytenoid cartilage position was classified as ‘intermediate’ at this dose, 3 with apposition of the vocal folds.…”
Section: Discussionsupporting
confidence: 54%
See 3 more Smart Citations
“…4 It has been suggested that the laryngeal muscles are more resistant to the effects of rocuronium than fibular or radial nerves, which could explain the apparent similarity in onset time between the reported case and earlier work. 4,6 In contrast, a feline study using subjective evaluation of intubating conditions as an outcome found a slower time to peak effect (60 s) with 0.6 mg/kg rocuronium IV. 3 Furthermore, arytenoid cartilage position was classified as ‘intermediate’ at this dose, 3 with apposition of the vocal folds.…”
Section: Discussionsupporting
confidence: 54%
“…1,5,6 A dose-finding study in cats observed a trend to faster onset of effect and reduced inter-individual variability (improved consistency) with increasing rocuronium doses (0.1–0.6 mg/kg), and visual examination of these data suggests that higher doses may result in a faster onset of effect (Figure 2). 4 The ED 90 of rocuronium in cats has been variably reported as 0.09–0.25 mg/kg. 7,8 High doses of rocuronium have not been clinically evaluated in cats, though an experimental study using an intravenous dose of 1.5 mg/kg reported a duration of action (until recovery of 75% of a twitch response) of approximately 30–40 mins.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…4 A recent dose-finding study in a laboratory setting evaluating the NMBA rocuronium in cats showed that reducing the dose of this agent from 0.6 to 0.3 mg/kg intravenously (IV) can significantly limit the time of apnea while preserving the ability to blunt laryngospasm in response to laryngeal stimulation. 6 However, to our knowledge, whether the technique improves tracheal intubation in a clinical setting has not yet been evaluated.…”
Section: Introductionmentioning
confidence: 99%